PMO-14 Use of non-invasive surrogate markers to monitor vedolizumab therapy in inflammatory bowel disease

Autor:	Stuart Bloom, Farooq Rahman, I Parisi, Edward Seward, Hajeena Saravanapavan, G Sebepos-Rogers, Shameer Mehta, Ho Juen Ko, Konstantinos C. Fragkos, Sara McCartney, J. Barragry, Hui Fen Koo
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Internal medicine Non invasive medicine medicine.disease business Gastroenterology Inflammatory bowel disease Vedolizumab medicine.drug
Zdroj:	Posters.
DOI:	10.1136/gutjnl-2021-bsg.153
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a1d115c33226d49471d901ccfd367f77 https://doi.org/10.1136/gutjnl-2021-bsg.153 Zobrazit plný text záznamu